HES1 and neoplasm: In these studies, the decrease in Hes-1 expression by presenilin blockage resulted in PTEN and GSK-3β activation [74], whereas inhibiting either PTEN or GSK-3β activation increases Hes-1 expression which counteracts their effects on inhibiting tumour cell proliferation [75].